NCT07783399 The Effects of Carnitine Supplementation on Oocytes in Women Undergoing IVF Process
| NCT ID | NCT07783399 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Obstetrics and Gynaecology Clinic Narodni Front |
| Condition | Infertility (IVF Patients) |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-05-15 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2026-05-15 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn whether supplementation with L-carnitine improves outcomes in women undergoing in vitro fertilization (IVF). It will also evaluate the effect of supplementation on oocyte quality, embryo quality, and pregnancy rates. The main questions it aims to answer are: * Does supplementation improve the number and quality of oocytes retrieved during IVF treatment? * Does supplementation improve the number and quality of embryos obtained after fertilization? * Does supplementation increase the rates of biochemical and clinical pregnancy? Researchers will compare women receiving supplementation with women not receiving supplementation to determine whether the supplements improve IVF outcomes.
Eligibility Criteria
Inclusion Criteria: * women undergoing IVF process * women aged 18-45 years Exclusion Criteria: * obesity * severe kidney disease * liver insufficiency * endocrine disorders * the use of immunosuppressive medications
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07783399 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Infertility (IVF Patients). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07783399 currently recruiting?
Yes, NCT07783399 is actively recruiting participants. Contact the research team at perovic.milan@gakfront.org for enrollment information.
Where is the NCT07783399 trial being conducted?
This trial is being conducted at Belgrade, Serbia.
Who is sponsoring the NCT07783399 clinical trial?
NCT07783399 is sponsored by The Obstetrics and Gynaecology Clinic Narodni Front. The trial plans to enroll 70 participants.